US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 30.480
  • +0.980+3.32%
Close Feb 14 16:00 ET
  • 30.500
  • +0.020+0.07%
Post 19:59 ET
3.40BMarket Cap-30.18P/E (TTM)

About Viking Therapeutics Company

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Lian, PhD
  • President, Chief Executive Officer and Director
  • 12.63M
  • Greg S. Zante
  • Chief Financial Officer and Principal Accounting Officer
  • 3.50M
  • Marianne Mancini
  • Chief Operating Officer
  • 3.51M
  • J. Matthew Singleton
  • Independent Director
  • 192.77K
  • Charles A. Rowland, Jr,M.B.A.
  • Independent Director
  • 189.62K
  • Dr. S. Kathryn Rouan, PhD
  • Independent Director
  • 178.65K
  • Matthew W. Foehr
  • Independent Director
  • 169.37K
  • Dr. Lawson Macartney, D.V.M.,PhD
  • Chairperson of the Board
  • 222.72K

Trending Stocks

Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More